Table 3:
Number of patients with AE |
Number of trials with AE any grade by threshold |
Association with trial size and phase (OR, 95% CI)* |
|
---|---|---|---|
Phase II vs I | Trial size ≥40 vs <40 |
||
1-2 patients | 46 (22%) | - | - |
5-10% incidence | 66 (32%) | −.3 (−1.0-0.5) | 1.6 (0.7-2.4) |
15-20% incidence | 30 (14%) | 0.6 (−0.3-1.6) | 2.0 (0.9-3.0) |
>=25% incidence | 5 (2%) | −15 (−1713-1684) | 0.9 (−1.0-2.8) |
Not reported | 62 (30%)* | 0.3 (−0.5-1.0) | 1.2 (0.4-2.1) |
Total | 209 |
Bold indiates p<0.05